Industry: Medical Devices & Consumables
Published Date: 2026-01-05
Pages: 124 Pages
Report ld: 5508715
Request Sample
Customized Report
EVA Infusion Bags Market Size(US$)

CAGR 2026-2032
6.0%
Market Size,2032
USD 461
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for EVA Infusion Bags was estimated to be worth US$ 308 million in 2025 and is projected to reach US$ 461 million, growing at a CAGR of 6.0% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on EVA Infusion Bags cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
EVA Infusion Bags are sterile, single-use medical devices that are used for the preparation, preservation and administration of parenteral solutions. They are usually made from PVC-free, DEHP-free and latex-free EVA material. In order to enable transferring additional ingredients (such as lipids) into a separate container to extend the beyond-use date (BUD) of the sterile solution, EVA Infusion Bags often come up with the form of single-chamber or multi-chambers.
Global key players of EVA Infusion Bags include Baxter International, B. Braun, Fresenius Kabi, Weigao Group, ICU Medical, etc. The top five players hold a share about 64%.
North America is the dominate consumption region of EVA Infusion Bags, accounting for about 40% of the total revenue, followed by APAC, with the consumption market share of 32%. EVA Infusion bag in the Asia-Pacific region once again grew substantially in 2024, due predominantly to an aging population, growing prosperity and the associated increase in health awareness. China is the most populous country in the world, with a rapidly growing percentage of elderly people. In order to manage this demographic challenge, the country’s health care system has been undergoing expansion and renovation for years.
In terms of product type, Multi-Chambers is the largest segment, occupied for a share of 51%. In terms of application, Hospital is the largest application, occupied for a share of 61%.
The growing demand for advanced drug delivery systems in healthcare. EVA infusion bags offer several advantages over traditional PVC (Polyvinyl Chloride) bags, including lower risk of leaching harmful chemicals, greater flexibility, and compatibility with a wider range of drugs. As healthcare providers and pharmaceutical companies prioritize patient safety and drug efficacy, the adoption of EVA infusion bags is increasing. Moreover, regulatory trends favoring the use of safer and more compatible materials in medical devices also contribute to the market growth of EVA infusion bags.
This report provides a comprehensive view of the global market for EVA Infusion Bags, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The EVA Infusion Bags market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding EVA Infusion Bags.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the EVA Infusion Bags manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents EVA Infusion Bags sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents EVA Infusion Bags sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 EVA Infusion Bags Product Introduction
1.2 Global EVA Infusion Bags Market Size Forecast
1.2.1 Global EVA Infusion Bags Sales Value (2021–2032)
1.2.2 Global EVA Infusion Bags Sales Volume (2021–2032)
1.2.3 Global EVA Infusion Bags Sales Price (2021–2032)
1.3 EVA Infusion Bags Market Trends & Drivers
1.3.1 EVA Infusion Bags Industry Trends
1.3.2 EVA Infusion Bags Market Drivers & Opportunities
1.3.3 EVA Infusion Bags Market Challenges
1.3.4 EVA Infusion Bags Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global EVA Infusion Bags Players Revenue Ranking (2025)
2.2 Global EVA Infusion Bags Revenue by Company (2021–2026)
2.3 Global EVA Infusion Bags Sales Volume Ranking of Players (2025)
2.4 Global EVA Infusion Bags Sales Volume by Company (2021–2026)
2.5 Global EVA Infusion Bags Average Price by Company (2021–2026)
2.6 Key Manufacturers EVA Infusion Bags Manufacturing Base and Headquarters
2.7 Key Manufacturers EVA Infusion Bags Product Offerings
2.8 Key Manufacturers Start of Mass Production of EVA Infusion Bags
2.9 EVA Infusion Bags Market Competitive Analysis
2.9.1 EVA Infusion Bags Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by EVA Infusion Bags Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on EVA Infusion Bags revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation EVA Infusion Bags Market Classification
3.1 Introduction by Type
3.1.1 Single Chamber
3.1.2 Multi Chamber
3.1.3 Global EVA Infusion Bags Sales Value by Type
3.1.3.1 Global EVA Infusion Bags Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global EVA Infusion Bags Sales Value, by Type (2021–2032)
3.1.3.3 Global EVA Infusion Bags Sales Value, by Type (%), 2021–2032
3.1.4 Global EVA Infusion Bags Sales Volume by Type
3.1.4.1 Global EVA Infusion Bags Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global EVA Infusion Bags Sales Volume, by Type (2021–2032)
3.1.4.3 Global EVA Infusion Bags Sales Volume, by Type (%), 2021–2032
3.1.5 Global EVA Infusion Bags Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global EVA Infusion Bags Sales Value by Application
4.2.1 Global EVA Infusion Bags Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global EVA Infusion Bags Sales Value, by Application (2021–2032)
4.2.3 Global EVA Infusion Bags Sales Value, by Application (%), 2021–2032
4.3 Global EVA Infusion Bags Sales Volume by Application
4.3.1 Global EVA Infusion Bags Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global EVA Infusion Bags Sales Volume, by Application (2021–2032)
4.3.3 Global EVA Infusion Bags Sales Volume, by Application (%), 2021–2032
4.4 Global EVA Infusion Bags Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global EVA Infusion Bags Sales Value by Region
5.1.1 Global EVA Infusion Bags Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global EVA Infusion Bags Sales Value by Region (2021–2026)
5.1.3 Global EVA Infusion Bags Sales Value by Region (2027–2032)
5.1.4 Global EVA Infusion Bags Sales Value by Region (%), 2021–2032
5.2 Global EVA Infusion Bags Sales Volume by Region
5.2.1 Global EVA Infusion Bags Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global EVA Infusion Bags Sales Volume by Region (2021–2026)
5.2.3 Global EVA Infusion Bags Sales Volume by Region (2027–2032)
5.2.4 Global EVA Infusion Bags Sales Volume by Region (%), 2021–2032
5.3 Global EVA Infusion Bags Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America EVA Infusion Bags Sales Value, 2021–2032
5.4.2 North America EVA Infusion Bags Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe EVA Infusion Bags Sales Value, 2021–2032
5.5.2 Europe EVA Infusion Bags Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific EVA Infusion Bags Sales Value, 2021–2032
5.6.2 Asia Pacific EVA Infusion Bags Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America EVA Infusion Bags Sales Value, 2021–2032
5.7.2 South America EVA Infusion Bags Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa EVA Infusion Bags Sales Value, 2021–2032
5.8.2 Middle East & Africa EVA Infusion Bags Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions EVA Infusion Bags Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions EVA Infusion Bags Sales Value and Sales Volume
6.2.1 Key Countries/Regions EVA Infusion Bags Sales Value, 2021–2032
6.2.2 Key Countries/Regions EVA Infusion Bags Sales Volume, 2021–2032
6.3 United States
6.3.1 United States EVA Infusion Bags Sales Value, 2021–2032
6.3.2 United States EVA Infusion Bags Sales Value by Type (%), 2025 vs 2032
6.3.3 United States EVA Infusion Bags Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe EVA Infusion Bags Sales Value, 2021–2032
6.4.2 Europe EVA Infusion Bags Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe EVA Infusion Bags Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China EVA Infusion Bags Sales Value, 2021–2032
6.5.2 China EVA Infusion Bags Sales Value by Type (%), 2025 vs 2032
6.5.3 China EVA Infusion Bags Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan EVA Infusion Bags Sales Value, 2021–2032
6.6.2 Japan EVA Infusion Bags Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan EVA Infusion Bags Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea EVA Infusion Bags Sales Value, 2021–2032
6.7.2 South Korea EVA Infusion Bags Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea EVA Infusion Bags Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia EVA Infusion Bags Sales Value, 2021–2032
6.8.2 Southeast Asia EVA Infusion Bags Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia EVA Infusion Bags Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India EVA Infusion Bags Sales Value, 2021–2032
6.9.2 India EVA Infusion Bags Sales Value by Type (%), 2025 vs 2032
6.9.3 India EVA Infusion Bags Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Baxter International
7.1.1 Baxter International Company Information
7.1.2 Baxter International Introduction and Business Overview
7.1.3 Baxter International EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Baxter International EVA Infusion Bags Product Offerings
7.1.5 Baxter International Recent Developments
7.2 B. Braun
7.2.1 B. Braun Company Information
7.2.2 B. Braun Introduction and Business Overview
7.2.3 B. Braun EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 B. Braun EVA Infusion Bags Product Offerings
7.2.5 B. Braun Recent Developments
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Information
7.3.2 Fresenius Kabi Introduction and Business Overview
7.3.3 Fresenius Kabi EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Fresenius Kabi EVA Infusion Bags Product Offerings
7.3.5 Fresenius Kabi Recent Developments
7.4 Weigao Group
7.4.1 Weigao Group Company Information
7.4.2 Weigao Group Introduction and Business Overview
7.4.3 Weigao Group EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Weigao Group EVA Infusion Bags Product Offerings
7.4.5 Weigao Group Recent Developments
7.5 ICU Medical
7.5.1 ICU Medical Company Information
7.5.2 ICU Medical Introduction and Business Overview
7.5.3 ICU Medical EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 ICU Medical EVA Infusion Bags Product Offerings
7.5.5 ICU Medical Recent Developments
7.6 Metrix
7.6.1 Metrix Company Information
7.6.2 Metrix Introduction and Business Overview
7.6.3 Metrix EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Metrix EVA Infusion Bags Product Offerings
7.6.5 Metrix Recent Developments
7.7 Technoflex
7.7.1 Technoflex Company Information
7.7.2 Technoflex Introduction and Business Overview
7.7.3 Technoflex EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Technoflex EVA Infusion Bags Product Offerings
7.7.5 Technoflex Recent Developments
7.8 Bexen Medical
7.8.1 Bexen Medical Company Information
7.8.2 Bexen Medical Introduction and Business Overview
7.8.3 Bexen Medical EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Bexen Medical EVA Infusion Bags Product Offerings
7.8.5 Bexen Medical Recent Developments
7.9 Eraser Medical
7.9.1 Eraser Medical Company Information
7.9.2 Eraser Medical Introduction and Business Overview
7.9.3 Eraser Medical EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Eraser Medical EVA Infusion Bags Product Offerings
7.9.5 Eraser Medical Recent Developments
7.10 Valmed
7.10.1 Valmed Company Information
7.10.2 Valmed Introduction and Business Overview
7.10.3 Valmed EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Valmed EVA Infusion Bags Product Offerings
7.10.5 Valmed Recent Developments
7.11 Kapsam Health Products
7.11.1 Kapsam Health Products Company Information
7.11.2 Kapsam Health Products Introduction and Business Overview
7.11.3 Kapsam Health Products EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Kapsam Health Products EVA Infusion Bags Product Offerings
7.11.5 Kapsam Health Products Recent Developments
7.12 Hemedis
7.12.1 Hemedis Company Information
7.12.2 Hemedis Introduction and Business Overview
7.12.3 Hemedis EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Hemedis EVA Infusion Bags Product Offerings
7.12.5 Hemedis Recent Developments
7.13 Velfor Group
7.13.1 Velfor Group Company Information
7.13.2 Velfor Group Introduction and Business Overview
7.13.3 Velfor Group EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Velfor Group EVA Infusion Bags Product Offerings
7.13.5 Velfor Group Recent Developments
7.14 Merit Pharmaceutical
7.14.1 Merit Pharmaceutical Company Information
7.14.2 Merit Pharmaceutical Introduction and Business Overview
7.14.3 Merit Pharmaceutical EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Merit Pharmaceutical EVA Infusion Bags Product Offerings
7.14.5 Merit Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 EVA Infusion Bags Industrial Chain
8.2 EVA Infusion Bags Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 EVA Infusion Bags Sales Model
8.5.2 Sales Channels
8.5.3 EVA Infusion Bags Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global EVA Infusion Bags market size was US$ 308 million in 2025 and is forecast to reach a readjusted size of US$ 461 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 97
USD 4250.00
(Single User License)
The global EVA Infusion Bags market was valued at US$ 308 million in 2025 and is anticipated to reach US$ 461 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 120
USD 2900.00
(Single User License)
The global EVA Infusion Bags market size was US$ 292 million in 2024 and is forecast to a readjusted size of US$ 437 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 94
USD 4250.00
(Single User License)
The global EVA Infusion Bags market is projected to grow from US$ 292 million in 2024 to US$ 437 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 162
USD 4900.00
(Single User License)
The global market for EVA Infusion Bags was estimated to be worth US$ 292 million in 2024 and is forecast to a readjusted size of US$ 437 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-06-15
Pages: 115
USD 3950.00
(Single User License)
The global EVA Infusion Bags market is projected to grow from US$ 308 million in 2025 to US$ 437 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
Published Date: 2025-06-15
Pages: 146
USD 4900.00
(Single User License)
The global market for EVA Infusion Bags was valued at US$ 292 million in the year 2024 and is projected to reach a revised size of US$ 437 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published Date: 2025-06-15
Pages: 97
USD 2900.00
(Single User License)
The global market for EVA Infusion Bags was estimated to be worth US$ 292 million in 2024 and is forecast to a readjusted size of US$ 438 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 114
USD 3950.00
(Single User License)
EVA Infusion Bags are sterile, single-use medical devices that are used for the preparation, preservation and administration of parenteral solutions. They are usually made from PVC-free, DEHP-free and latex-free EVA material. In order to enable transferring additional ingredients (such as lipids) into a separate container to extend the beyond-use date (BUD) of the sterile solution, EVA Infusion Bags often come up with the form of single-chamber or multi-chambers.
Published Date: 2024-08-22
Pages: 137
USD 4350.00
(Single User License)
EVA Infusion Bags are sterile, single-use medical devices that are used for the preparation, preservation and administration of parenteral solutions. They are usually made from PVC-free, DEHP-free and latex-free EVA material. In order to enable transferring additional ingredients (such as lipids) into a separate container to extend the beyond-use date (BUD) of the sterile solution, EVA Infusion Bags often come up with the form of single-chamber or multi-chambers.
Published Date: 2024-08-22
Pages: 115
USD 3950.00
(Single User License)
The global EVA Infusion Bags market size was US$ 308 million in 2025 and is forecast to reach a readjusted size of US$ 461 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 97
The global EVA Infusion Bags market was valued at US$ 308 million in 2025 and is anticipated to reach US$ 461 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-01-05
Pages: 120
The global EVA Infusion Bags market size was US$ 292 million in 2024 and is forecast to a readjusted size of US$ 437 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 94
The global EVA Infusion Bags market is projected to grow from US$ 292 million in 2024 to US$ 437 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 162
The global market for EVA Infusion Bags was estimated to be worth US$ 292 million in 2024 and is forecast to a readjusted size of US$ 437 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-06-15
Pages: 115
The global EVA Infusion Bags market is projected to grow from US$ 308 million in 2025 to US$ 437 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
Published: 2025-06-15
Pages: 146
The global market for EVA Infusion Bags was valued at US$ 292 million in the year 2024 and is projected to reach a revised size of US$ 437 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-06-15
Pages: 97
The global market for EVA Infusion Bags was estimated to be worth US$ 292 million in 2024 and is forecast to a readjusted size of US$ 438 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 114
EVA Infusion Bags are sterile, single-use medical devices that are used for the preparation, preservation and administration of parenteral solutions. They are usually made from PVC-free, DEHP-free and latex-free EVA material. In order to enable transferring additional ingredients (such as lipids) into a separate container to extend the beyond-use date (BUD) of the sterile solution, EVA Infusion Bags often come up with the form of single-chamber or multi-chambers.
Published: 2024-08-22
Pages: 137
EVA Infusion Bags are sterile, single-use medical devices that are used for the preparation, preservation and administration of parenteral solutions. They are usually made from PVC-free, DEHP-free and latex-free EVA material. In order to enable transferring additional ingredients (such as lipids) into a separate container to extend the beyond-use date (BUD) of the sterile solution, EVA Infusion Bags often come up with the form of single-chamber or multi-chambers.
Published: 2024-08-22
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now